[HTML][HTML] Update on the management of diabetic retinopathy: Anti-VEGF agents for the prevention of complications and progression of nonproliferative and proliferative …
Diabetic retinopathy (DR) is a microvascular disease caused by poorly controlled blood
glucose, and it is a leading cause of vision loss in people with diabetes. In this review we …
glucose, and it is a leading cause of vision loss in people with diabetes. In this review we …
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
MJ Martinez-Zapata, I Salvador… - Cochrane Database …, 2023 - cochranelibrary.com
Background Proliferative diabetic retinopathy (PDR) is an advanced complication of diabetic
retinopathy that can cause blindness. It consists of the presence of new vessels in the retina …
retinopathy that can cause blindness. It consists of the presence of new vessels in the retina …
[HTML][HTML] Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
Z Xie, X Xiao - Frontiers in Endocrinology, 2022 - frontiersin.org
The global burden due to microvascular complications in patients with diabetes mellitus
persists and even increases alarmingly, the intervention and management are now …
persists and even increases alarmingly, the intervention and management are now …
[HTML][HTML] Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
Q Tang, F Buonfiglio, EW Böhm, L Zhang, N Pfeiffer… - Antioxidants, 2024 - mdpi.com
Diabetic retinopathy (DR) represents a severe complication of diabetes mellitus,
characterized by irreversible visual impairment resulting from microvascular abnormalities …
characterized by irreversible visual impairment resulting from microvascular abnormalities …
[HTML][HTML] Regression of Neovascularization after Panretinal Photocoagulation Combined with Anti-VEGF Injection for Proliferative Diabetic Retinopathy—A Review
M Gawęcki, K Kiciński, L Bianco, M Battaglia Parodi - Diagnostics, 2023 - mdpi.com
Proliferative diabetic retinopathy (PDR) poses a significant therapeutic problem that often
results in severe visual loss. Panretinal photocoagulation (PRP) has long been a mainstay …
results in severe visual loss. Panretinal photocoagulation (PRP) has long been a mainstay …
[HTML][HTML] Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy
R Anguita, LF Desideri, P Schwember, N Shah… - American Journal of …, 2024 - Elsevier
Objective To compare the clinical outcomes of early pars plana vitrectomy (PPV) versus
delayed PPV in patients with first episode of vitreous hemorrhage (VH) secondary to …
delayed PPV in patients with first episode of vitreous hemorrhage (VH) secondary to …
[HTML][HTML] Panretinal photocoagulation plus intravitreal conbercept for diabetic retinopathy in real world: a retrospective study
X Wang, J Yao, S Li, W Zhang, L Wang, A Zhou - BMC ophthalmology, 2023 - Springer
Background To evaluate outcomes of panretinal photocoagulation (PRP) plus intravitreal
conbercept (IVC) for diabetic retinopathy (DR) in real world and explore risk factors for …
conbercept (IVC) for diabetic retinopathy (DR) in real world and explore risk factors for …
Treatment of Proliferative Diabetic Retinopathy in 2023
M Reding, A Loya, CY Weng - International Ophthalmology Clinics, 2024 - journals.lww.com
Diabetes mellitus (DM) is a multisystem disease with a rapidly rising incidence over recent
decades. 1, 2 Its ophthalmic effects cannot be understated, as diabetic retinopathy (DR) is …
decades. 1, 2 Its ophthalmic effects cannot be understated, as diabetic retinopathy (DR) is …